Bridging development and GMP: Leveraging pilot-scale viral vector production to advance cell therapies
Conference Dates
February 1 – 5, 2026
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Andrew Gates, "Bridging development and GMP: Leveraging pilot-scale viral vector production to advance cell therapies" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/17
50.pdf (75 kB)
COinS